ASHLAND: 541-488-3192
MEDFORD: 541-200-3300
GRANTS PASS: 541-956-6471

CLINICAL
STUDIES

Research

The Retina & Vitreous Center is committed to being on the cutting edge of medical care for vitreoretinal disease. For over fifteen years, we have participated in numerous FDA approved clinical trials, including dry macular degeneration, wet macular degeneration, diabetic macular edema, and uveitis.

We strive to provide our patients with the most advanced care. The field of retina has evolved greatly over the past decade, and it is our goal to continue our research in the hope that one day we may be able to provide less intrusive, more successful treatment, or a cure for one or more of these devastating, blinding conditions.

We have four active clinical trials that are open for enrollment for dry and wet Advanced Macular Degeneration and Diabetic Macular Edema.  If you are interested in finding out more about these studies, please contact our study coordinator or call our office.

Retina & Vitreous Center Macular Research Institute

If you are interested in participating in a clinical trial,
please contact one of our study coordinator:

Becca Brower – beccab@rvcso.com

541-488-3192

Macular Research Institute clinical studies team
Retina and Vitreous Center of Southern Oregon

© Retina & Vitreous Center, PC. All rights reserved. Site developed and hosted by Rogue Web Works.
Proudly serving the communities of The Applegate Valley, Ashland, Bandon, Bend, Brookings, Butte Falls, Canyonville, Cave Junction Central Point, Chiloquin, Coos Bay, Crescent City, Dillard, Dunsmuir, Eagle Point, Eugene, Glendale, Glide, Gold Beach, Grants Pass, Jacksonville, Klamath Falls, Lake Creek, Lake Shastina, Lakeview, Medford, Merlin, Mt. Shasta, Murphy, Myrtle Creek, Northern California Coast, Phoenix, Port Orford, Prospect, Provolt, Rogue River, The Rogue Valley, Redding, Riddle, Roseburg, Ruch, Sams Valley, Shady Cove, Southern Oregon Coast, Sunny Valley, Talent, Trail, Weed, White City, Williams,Winston, Wolf Creek, Yreka, and beyond.